EMD Serono, a US subsidiary of German pharmaceutical firm Merck KGaA, says Drew Young has joined the company as Senior Vice President, Neurology and Immunology. In this capacity, he will be responsible for leading the strategic direction of the US Neurology and Immunology franchise, including future products.
Bringing more than 20 years of experience leading global and US marketing and sales efforts at pharmaceutical and biotech companies, Young comes to EMD Serono from Biogen Idec, where he was the Marketing Lead of the interferon franchise for the company's multiple sclerosis (MS) business.
EMD Serono's neurology franchise is led by Rebif (interferon beta-1a) for the treatment of relapsing MS.
Among other roles, Young has worked with Bristol-Myers Squibb Pharmaceutical Group (BMS) in both Canada and the US, where he held numerous sales and marketing roles of increasing responsibility. He has also held senior sales and marketing positions at Schering Plough Canada and Novartis Pharmaceuticals Canada.
